Literature DB >> 2530454

Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum.

P James1, M Inui, M Tada, M Chiesi, E Carafoli.   

Abstract

The rapid removal of Ca2+ ions from the cytosol, necessary for the efficient relaxation of cardiac muscle cells, is performed by the Ca2+-pumping ATPase of the sarcoplasmic reticulum. The calcium pump is activated by cyclic AMP- and calmodulin-dependent phosphorylation of phospholamban, an integral membrane protein of the sarcoplasmic reticulum. Using a heterobifunctional crosslinking agent which can be cleaved and photoactivated, we provide evidence for a direct interaction between the two proteins. Only the non-phosphorylated form of phospholamban interacts with the ATPase, demonstrating that phospholamban is an endogenous inhibitor that is removed from the ATPase by phosphorylation. Non-phosphorylated phospholamban interacts only with the calcium-free conformation of the ATPase and is released when it is converted to the calcium-bound state. We localized the site of interaction to a single peptide isolated after cyanogen bromide cleavage of the ATPase. The peptide derives from a domain just C-terminal to the aspartyl phosphate of the active site. This domain is unique to ATPases of the sarcoplasmic reticulum in that it has no homology with any other phosphorylation-type ion pump. The domain occurs in both slow- and fast-twitch isoforms of the ATPase, even though phospholamban is not expressed in fast-twitch muscles.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2530454     DOI: 10.1038/342090a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  99 in total

1.  Modeling a dehalogenase fold into the 8-A density map for Ca(2+)-ATPase defines a new domain structure.

Authors:  D L Stokes; N M Green
Journal:  Biophys J       Date:  2000-04       Impact factor: 4.033

2.  Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases.

Authors:  M Asahi; N M Green; K Kurzydlowski; M Tada; D H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

3.  Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopy.

Authors:  H S Young; L R Jones; D L Stokes
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

Review 4.  Structural similarities of Na,K-ATPase and SERCA, the Ca(2+)-ATPase of the sarcoplasmic reticulum.

Authors:  K J Sweadner; C Donnet
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

5.  Cytoplasmic interactions between phospholamban residues 1-20 and the calcium-activated ATPase of the sarcoplasmic reticulum.

Authors:  P Sharma; V B Patchell; Y Gao; J S Evans; B A Levine
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

6.  An autoinhibitory peptide from the erythrocyte Ca-ATPase aggregates and inhibits both muscle Ca-ATPase isoforms.

Authors:  L G Reddy; Y Shi; H Kutchai; A G Filoteo; J T Penniston; D D Thomas
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

7.  Functional and physical competition between phospholamban and its mutants provides insight into the molecular mechanism of gene therapy for heart failure.

Authors:  Elizabeth L Lockamy; Razvan L Cornea; Christine B Karim; David D Thomas
Journal:  Biochem Biophys Res Commun       Date:  2011-04-12       Impact factor: 3.575

Review 8.  Structural features of cation transport ATPases.

Authors:  G Inesi; M R Kirtley
Journal:  J Bioenerg Biomembr       Date:  1992-06       Impact factor: 2.945

9.  Functional difference between SERCA2a and SERCA2b Ca2+ pumps and their modulation by phospholamban.

Authors:  H Verboomen; F Wuytack; H De Smedt; B Himpens; R Casteels
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

10.  Correlated expression of the 97 kDa sarcoendoplasmic reticulum Ca(2+)-ATPase and Rap1B in platelets and various cell lines.

Authors:  C Magnier; R Bredoux; T Kovacs; R Quarck; B Papp; E Corvazier; J de Gunzburg; J Enouf
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.